Logo American Journal of Case Reports

Call: 1.631.629.4328
Mon-Fri 10 am - 2 pm EST

Contact Us

Logo American Journal of Case Reports Logo American Journal of Case Reports Logo American Journal of Case Reports

11 August 2021: Articles  Denmark

A 19-Year-Old Man with a History of Recreational Inhalation of Nitrous Oxide with Severe Peripheral Neuropathy and Central Pulmonary Embolism

Unusual clinical course, Challenging differential diagnosis

Oliver Buchhave Pedersen C , Anne-Mette Hvas C , Erik Lerkevang Grove A*

DOI: 10.12659/AJCR.931936

Am J Case Rep 2021; 22:e931936



BACKGROUND: Recreational use of nitrous oxide (laughing gas) is a growing phenomenon among young people due to easy accessibility and a presumed innocent effect. However, complications have been reported, especially following high and long-term use, including nerve damage, spontaneous pneumo-mediastinum, myocardial infarction, and macrocytic anemia.

CASE REPORT: We report a case of a 19-year-old previously healthy man with occasional recreational use of nitrous oxide of up to 10 times within recent months, who presented with severe peripheral neuropathy. Laboratory examination revealed severely elevated homocysteine values of 92 µmol/L (reference range, <10 µmol/L), strongly elevated methylmalonic acid level of >10 µmol/L (range, 0.1-0.4 µmol/L), vitamin B₁₂ level of 234 pmol/L (range, 200-600 pmol/L), hemoglobin level of 9.3 mmol/L (range, 8.3-10.5 mmol/L), platelets of 384×10⁹/L (range, 145-350×10⁹/L), and leucocytes of 6.2×10⁹/L (range, 3.5-10.0×10⁹/L). Nitrous oxide can result in vitamin B₁₂ inactivation and nerve damage due to lack of myelination. During hospitalization, the patient had a bilateral central pulmonary embolism, probably caused by a combination of nitrous oxide abuse and some extent of immobilization. After 6 months of nitrous oxide cessation and treatment with B vitamins, the patient experienced almost no residual symptoms, and homocysteine and methylmalonic acid levels normalized.

CONCLUSIONS: Our case shows that even moderate recreational use of nitrous oxide can lead to severe peripheral neuropathy as well as increase the risk of thromboembolic complications. Especially young and previously healthy individuals presenting with unexplained neuropathy or thromboembolic events should therefore be asked about possible use of nitrous oxide.

Keywords: homocysteine, Nitrous Oxide, Peripheral Nervous System Diseases, Pulmonary Embolism, case reports, Adolescent, Adult, Male, Vitamin B 12, Vitamin B 12 Deficiency, young adult


Nitrous oxide has been used as an anesthetic for more than a century [1]. However, nitrous oxide in the form of so-called “laughing gas” is an increasingly used drug among young people [2]. This is owing to a presumed innocent effect combined with an easy and legal availability, as nitrous oxide can be easily obtained from, for example, whipped cream charging bottles [2]. Daily, large-scale (more than 200 cartridges), and long-term recreational use of nitrous oxide has been associated with nerve damage due to functional vitamin B12 deficiency [1,3,4]. Furthermore, various complications, including nerve damage, macrocytic anemia, thromboembolic phenomena, myocardial infarction, and spontaneous pneumo-mediastinum, have been associated with daily and long-term recreational use of nitrous oxide [5–11]. Deaths have also been described as a result of recreational use of nitrous oxide, presumably triggered by hypoxia [2,12].

This report is a case of a 19-year-old man with no preexisting cause of peripheral neuropathy but a recreational inhalation of nitrous oxide, who presented with peripheral neuropathy and had a pulmonary embolism during hospitalization.

Case Report

A 19-year-old man who was previously healthy without any medication or predisposition presented to the Emergency Department after falling down a staircase. He explained that, during the past 4 to 5 weeks, he had experienced increasing sensory disturbances in the hands and lower extremities and now experienced balance impairment and muscle weakness in the lower extremities. An extensive workup was performed, including neurological examination, lumbar puncture, electroneuronography, and magnetic resonance imaging (MRI) of the medulla totalis. The patient’s lumbar puncture and electroneuronography results were normal, and no definite pathological signal changes were recognized on the MRI scan (Figure 1). Furthermore, laboratory examination revealed highly elevated homocysteine values of 92 µmol/L (reference range, <10 µmol/L), strongly elevated methylmalonic acid level of >10 µmol/L (range, 0.08–0.28 µmol/L), normal folate level of 21 nmol/L (range, >9 nmol/L), normal vitamin B12 level of 234 pmol/L (range, 200–600 pmol/L), and a normal creatinine level of 61 µmol/L (range, 60–105 µmol/L) (Table 1). All other laboratory results were within the reference range (Table 1). Based on this extensive workup, the patient was diagnosed with severe sensorimotor neuropathy. The initial presumed diagnoses included Guillain-Barre syndrome, neurological infection, and other causes of neuropathy. However, based on the patient’s history and diagnostic workup, including laboratory results, it was concluded that the patient had sensorimotor neuropathy due to functional vitamin B12 deficiency. A potential underlying trigger was suggested to be moderate recreational use of nitrous oxide on various occasions, primarily on weekends. The patient claimed to had used nitrous oxide about twice per week within recent months (maximum of 50–75 cartridges per time), which the patient confirmed to several health professionals. The patient denied the use of other forms of recreational drugs. The patient received oral vitamin treatment with 1 mg once-daily vitamin B12, 5 mg once-daily folate (vitamin B9), and 300 mg once-daily thiamin (vitamin B1) and started physiotherapy treatment. The symptoms improved considerably during hospitalization, and after 14 days, the patient was ready for discharge for further outpatient treatment at a rehabilitation center. However, just before discharge, the patient suddenly developed severe non-radiating thoracic pain. The pain was worsened by deep inspiration. His vital signs were blood pressure of 112/64 mm Hg, pulse of 86 beats per min, and oxygen saturation of 98%. An acute computed tomography angiography of the aorta was performed on suspicion of aortic dissection. No dissection was found; however, bilateral central pulmonary embolism with signs of pulmonary infarction in both lower lobes with consolidated changes was found. Because the patient was completely hemodynamically stable and had a normal echocardiography, the pulmonary embolism was treated with an oral anticoagulant (20 mg once-daily rivaroxaban). After a few days of further hospitalization, the patient was discharged.

At clinical follow-up 6 months after hospitalization, only mild sensory-motor residual symptoms were present. The patient had no symptoms related to pulmonary embolism or anticoagulant treatment. A thrombophilia screening was performed, but all tests were normal, including no antiphospholipid antibodies or lupus anticoagulant, no genetic polymorphisms, and no lack of natural anticoagulants, (Table 1). In addition, the homocysteine level had been completely normalized (9.5 µmol/L) (Table 1). Based on these findings, the anticoagulant treatment was stopped.


Our patient had both severe peripheral neuropathy and bilateral central pulmonary embolism, presumably due to functional vitamin B12 deficiency and increased level of homocysteine after moderate recreational use of nitrous oxide. In addition, after 6 months of total nitrous oxide cessation, the patient experienced almost no residual symptoms.

Peripheral neuropathy following recreational use of nitrous oxide has been reported previously, primarily in cases of long-term use [13–15]. Chronic use of nitrous oxide leads to functional vitamin B12 deficiency due to irreversible inactivation of vitamin B12 [2,16]. Active vitamin B12 is required for the conversion of methylmalonic acid and the degeneration of homocysteine to methionine, hence persistent inactivation of vitamin B12 by nitrous oxide results in elevated levels of methylmalonic acid and homocysteine [13,17] (Figure 2). As methionine is required for all methylations, vitamin B12 inactivation caused by the use of nitrous oxide can cause nerve damage due to lack of myelination of the nerve cell axons [13,18]. This mechanism is also a likely explanation for the peripheral neuropathy in our patient, as laboratory examinations at admission revealed elevated levels of methylmalonic acid and homocysteine, whereas plasma levels of vitamin B12 and folate as well as creatinine were normal. Although the patient’s vitamin B12 level was normal, the amount of cobalamin available for the cells can still be suboptimal and result in the experienced symptoms, as only the cobalamin bound to transcobalamin are available for circulation [19]. Unfortunately, transcobalamin was not measured in the patient. Furthermore, the MRI scan did not reveal any definite pathological findings. Following nitrous oxide cessation, the inactivation of vitamin B12 no longer persisted, leading to normalization of blood levels and restoration of nerve cell myelination. We believe that the rapid fall/normalization in homocysteine level supports the hypothesis that it is most likely the use of nitrous oxide causing the substantial increase in homocysteine level and the cessation causing the normalization.

Our patient had a pulmonary embolism 2 weeks after admission. Immobilization is a well-known risk factor for thromboembolic complications [20] and might be of importance regarding this case, as the patient primarily stayed in his own hospital room during hospitalization. However, the patient was not immobile and could still walk despite peripheral neuropathy. The use of nitrous oxide may also have contributed to the development of the pulmonary embolism. Accordingly, one case has previously been reported on pulmonary embolism following the recreational use of nitrous oxide, although this patient had long-term use [6]. Among potential reasons for the increased risk of thromboembolic complications is the highly increased level of homocysteine [6,21,22]. An increased level of homocysteine has been reported to have various effects regarding hemostasis including endothelium dysfunction, platelet activation, and impaired fibrinolysis, which can also increase the risk of myocardial infarction [23–25]. However, these consequences of increased homocysteine by nitrous oxide may not account for all effects of nitrous oxide on hemostasis. In a case report on a patient with an aortic arch thrombus following recreational use of nitrous oxide, the author suggested that since this thrombus occurred in an artery, a strong factor contributing to a hypercoagulable state must be present, and believed this factor to be nitrous oxide because the patient did not have any other major risk factors [26]. In addition, another case of a patient with isolated cortical vein thrombosis after long-term recreational use of nitrous oxide found a normal homocysteine level upon admission [27]. However, as our patient had a pulmonary embolism about 2 weeks after his last recreational use of nitrous oxide, the direct contributing effect of nitrous oxide on the development of pulmonary embolism was uncertain.


This report shows that even moderate recreational use of nitrous oxide can lead to severe peripheral neuropathy due to functional vitamin B12 deficiency and can be associated with pulmonary embolism, even in young and previously healthy individuals. Complete cessation of nitrous oxide use and treatment with relevant vitamins can lead to a rapid return to normal conditions. Due to an increasing consumption among young people, healthcare professionals should explore the possible recreational use of nitrous oxide in patients presenting with unexplained neuropathy or thromboembolic events. Furthermore, it is important that young people in particular are informed about this risk of adverse effects of the recreational use of nitrous oxide.


1.. Emmanouil DE, Quock RM: Anesth Prog, 2007; 54; 9-18

2.. van Amsterdam J, Nabben T, van den Brink W: Regul Toxicol Pharmacol, 2015; 73; 790-96

3.. Stockton L, Simonsen C, Seago S: Proc (Bayl Univ Med Cent), 2017; 30; 171-72

4.. Samia AM, Nenow J, Price D: Cureus, 2020; 12; e11041

5.. Chanarin I: Crit Rev Toxicol, 1982; 10; 179-213

6.. Sun W, Liao JP, Hu Y: World J Clin Case, 2019; 7; 4057-62

7.. Weimann J: Best Prac Res Clin Anaesthesiol, 2003; 17; 47-61

8.. McDermott R, Tsang K, Hamilton N, Belton M: Br Med J Case Rep, 2015; 2015; bcr2015209750

9.. Amess JA, Burman JF, Rees GM: Lancet (London, England), 1978; 2; 339-42

10.. Leslie K, Myles PS, Chan MT: Anesth Analg, 2011; 112; 387-93

11.. Myles PS, Chan MT, Leslie K: Br J Anaesth, 2008; 100; 780-86

12.. Potocka-Banas B, Majdanik S, Dutkiewicz G: Human Exp Toxicol, 2011; 30; 1875-77

13.. Richardson PG: Emerg Med Australas, 2010; 22; 88-90

14.. Hirvioja J, Joutsa J, Wahlsten P, Korpela J: Oxford Med Case Rep, 2016; 2016; 41-43

15.. Egan W, Steinberg E, Rose J: Am J Emerg Med, 2018; 36; 1717 e1–.e2

16.. Schilling RF: JAMA, 1986; 255; 1605-6

17.. Waclawik AJ, Luzzio CC, Juhasz-Pocsine K, Hamilton V: Wis Med J, 2003; 102; 43-45

18.. Green R, Kinsella LJ: Neurology, 1995; 45; 1435-40

19.. Harrington DJ: J Clin Pathol, 2017; 70; 168-73

20.. Wells PS, Anderson DR, Rodger M: Thromb Hemost, 2000; 83; 416-20

21.. Caldera A, Mora J, Kotler M, Eiger G: Chest, 2002; 122; 1487-88

22.. Lupi-Herrera E, Soto-López ME, Lugo-Dimas AJ: Clin Appl Thromb Hemost, 2019; 25; 1076029618780344

23.. Cellai AP, Lami D, Antonucci E: J Thromb Thrombolysis, 2014; 38; 45-49

24.. Martí-Carvajal AJ, Solà I, Lathyris D, Dayer M: Cochrane Database Syst Rev, 2017; 8; CD006612

25.. Wald DS, Law M, Morris JK: BMJ (Clin Res ed), 2002; 325; 1202

26.. den Uil SH, Vermeulen EGJ, Metz R: J Vasc Surg Cases Innov Tech, 2018; 4; 80-82

27.. Liu M, Zhang J, Bu B: BMC Neurol, 2020; 20; 378


19 May 2022 : Case report  Serbia

Bilateral Emphysematous Pyelonephritis Associated with COVID Pneumonia: A Case Report

Am J Case Rep In Press; DOI: 10.12659/AJCR.936370  

17 May 2022 : Case report  USA

High-Frequency Oscillatory Ventilation for Refractory Hypoxemia in Severe COVID-19 Pneumonia: A Small Case ...

Am J Case Rep In Press; DOI: 10.12659/AJCR.936651  

13 May 2022 : Case report  Japan

A case of exacerbation of haloperidol-induced rhabdomyolysis following the onset of COVID-19

Am J Case Rep In Press; DOI: 10.12659/AJCR.936589  

13 May 2022 : Case report  USA

Acute Disseminated Encephalomyelitis After SARS-CoV-2 Vaccination

Am J Case Rep In Press; DOI: 10.12659/AJCR.936574  

In Press

20 May 2022 : Case report  Canada

Diagnostic Puzzle of Acute Ischemic Stroke Mimics – Seizure Versus Post-Stroke Recrudescence: A Case Report

Am J Case Rep In Press; DOI: 10.12659/AJCR.936826  

19 May 2022 : Case report  Saudi Arabia

Extremes of Anemia: The Lowest Hemoglobin Values Probably Ever Reported in the Pediatric Literature Attribu...

Am J Case Rep In Press; DOI: 10.12659/AJCR.936252  

19 May 2022 : Case report  Brazil

Acute Hepatitis with Positive Autoantibodies: A Case of Natalizumab-Induced Early-Onset Liver Injury

Am J Case Rep In Press; DOI: 10.12659/AJCR.936318  

19 May 2022 : Case report  Japan

Successful Percutaneous Fogarty Thrombectomy for Subacute Lower Limb Ischemia Due to Resistant Thrombus in ...

Am J Case Rep In Press; DOI: 10.12659/AJCR.936377  

Most Viewed Current Articles

31 Dec 1969 : Case report  USA

Penile Necrosis Associated with Local Intravenous Injection of Cocaine

DOI :10.12659/AJCR.935250

Am J Case Rep 2022; 23:e935250

31 Dec 1969 : Case report  Oman

Myocarditis, Pulmonary Hemorrhage, and Extensive Myositis with Rhabdomyolysis 12 Days After First Dose of P...

DOI :10.12659/AJCR.934399

Am J Case Rep 2022; 23:e934399

31 Dec 1969 : Case report  Brazil

Lipedema Can Be Treated Non-Surgically: A Report of 5 Cases

DOI :10.12659/AJCR.934406

Am J Case Rep 2021; 22:e934406

31 Dec 1969 : Case report  USA

A Rare Case of Coronavirus Disease 2019 Vaccine-Associated Cerebral Venous Sinus Thrombosis Treated with Me...

DOI :10.12659/AJCR.935355

Am J Case Rep 2022; 23:e935355

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

American Journal of Case Reports eISSN: 1941-5923
American Journal of Case Reports eISSN: 1941-5923